ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,780.05
      -0.21%
      US Tech 100
      19,731.60
      0.03%
      Dow Jones
      42,454.12
      -0.14%
      Brent Oil
      78.965
      -0.12%
      Bitcoin
      60,167.01
      -0.17%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Maravai LifeSciences Holdings Inc (MRVI) Quote

      Maravai LifeSciences Holdings Inc

      Maravai LifeSciences Holdings Inc (MRVI)

      NASDAQ
      7.63
      -0.06
      (-0.78%)
      Closed October 10 4:00PM
      Delayed by 15 minutes
      7.63
      0.00
      (0.00%)
      After Hours: 4:36PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      7.63
      Bid
      7.65
      Ask
      7.99
      Volume
      858,170
      7.475 Day's Range 7.72
      4.52 52 Week Range 11.555
      Market Cap
      1.925B
      Previous Close
      7.69
      Open
      7.63
      Last Trade
      113
      @
      7.63
      (formt)
      Last Trade Time
      Financial Volume
      $ 6,539,198
      VWAP
      7.6199
      Average Volume (3m)
      2,011,961
      Shares Outstanding
      252,237,419
      Dividend Yield
      -
      PE Ratio
      -16.17
      Earnings Per Share (EPS)
      -0.47
      Revenue
      292.23M
      Net Profit
      -119.03M

      About Maravai LifeSciences Holdings Inc

      Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It ... Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Maravai LifeSciences Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MRVI. The last closing price for Maravai LifeSciences was $7.69. Over the last year, Maravai LifeSciences shares have traded in a share price range of $ 4.52 to $ 11.555.

      Maravai LifeSciences currently has 252,237,419 shares outstanding. The market capitalization of Maravai LifeSciences is $1.94 billion. Maravai LifeSciences has a price to earnings ratio (PE ratio) of -16.17.

      Ask ADVFN Intelligence (AI)

      MRVI Latest News

      More News

      FeaturedZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use

      12 hours ago

      FeaturedCBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products

      12 hours ago

      TriLink BioTechnologies® und Alphazyme bringen die neue CleanScribe™ RNA Polymerase auf den Markt

      Arzneimittelentwicklern und Forschern können ab sofort das CleanScribe-Enzym nutzen, um die Bildung von dsRNA bei der mRNA-Synthese um bis zu 85 % zu reduzieren – ohne Beeinträchtigung von...

      September 25 2024
      Business Wire

      TriLink BioTechnologies® et Alphazyme collaborent pour lancer la nouvelle ARN polymérase CleanScribe™

      Les développeurs de médicaments et les chercheurs peuvent désormais tirer parti de l’enzyme CleanScribe pour réduire la formation d’ARNdb jusqu’à 85 % lors de la synthèse d’ARNm, sans...

      September 25 2024
      Business Wire

      TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe™ RNA Polymerase

      Drug developers & researchers can now leverage the CleanScribe enzyme to reduce dsRNA formation by up to 85% in mRNA synthesis without compromising mRNA yield, capping efficiency, or...

      September 24 2024
      Business Wire

      Form 8-K - Current report

      September 12 2024
      Edgar (US Regulatory)

      Cygnus Technologies and TriLink BioTechnologies® Collaborate to Launch AccuRes™ Host Cell DNA Quantification Kits

      Cygnus’ AccuRes Kits to recover, amplify, & quantify remaining host cell DNA during biologic drug manufacturing to produce safer, more stable vaccines, therapies, and more Cygnus Technologies...

      August 28 2024
      Business Wire

      Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule

      SAN DIEGO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is...

      August 12 2024
      GlobeNewswire Inc.

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      August 08 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      August 07 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.12-1.548387096777.757.9957.52510068607.74062003CS
      4-1.25-14.07657657668.889.57.52514424788.39365125CS
      12-1.57-17.06521739139.210.037.4320119618.83209299CS
      26-0.68-8.182912154038.3111.5556.6720537668.61663619CS
      52-1.41-15.59734513279.0411.5554.5223669717.52208035CS
      156-32.89-81.16979269540.5246.434.52206281516.19063552CS
      260-23.48-75.474124075931.1163.554.52192291020.1251752CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      BLMZBloomZ Inc
      $ 1.3301
      (85.98%)
      		81.27M
      MLGOMicroAlgo Inc
      $ 0.371
      (47.22%)
      		203.8M
      XHGXChange TED Inc
      $ 0.2454
      (37.09%)
      		220.36M
      RNAZTransCode Therapeutics Inc
      $ 0.7294
      (34.85%)
      		4.4M
      CNEYCN Energy Group Inc
      $ 0.7096
      (34.70%)
      		27.04M
      GRTSGritstone bio Inc
      $ 0.062
      (-68.75%)
      		151.88M
      CLIKClick Holdings Ltd
      $ 1.50
      (-43.18%)
      		1.22M
      MNTSMomentus Inc
      $ 0.6376
      (-39.85%)
      		29.59M
      CETXCemtrex Inc
      $ 0.46
      (-35.21%)
      		16.12M
      DUOFangDD Network Group Ltd
      $ 1.215
      (-30.97%)
      		24.74M
      JTAIJet AI Inc
      $ 0.08135
      (-12.15%)
      		811.42M
      NVDANVIDIA Corporation
      $ 134.81
      (1.63%)
      		242.29M
      XHGXChange TED Inc
      $ 0.2454
      (37.09%)
      		220.36M
      MLGOMicroAlgo Inc
      $ 0.371
      (47.22%)
      		203.8M
      GRTSGritstone bio Inc
      $ 0.062
      (-68.75%)
      		154.01M

      MRVI Discussion

      View Posts
      Monksdream Monksdream 8 months ago
      MRVI No 2 on the Barchart 100
      https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
      👍️0
      Monksdream Monksdream 8 months ago
      Early Barchart 100
      https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
      👍️0
      crudeoil24 crudeoil24 4 years ago
      Maravai LifeSciences stock price target raised to $50 from $31 at Stifel Nicolaus
      7:24 am ET March 3, 2021 (MarketWatch)
      👍️0
      crudeoil24 crudeoil24 4 years ago
      Maravai LifeSciences shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued FY21 EPS and sales guidance above estimates.

      Mar 3, 2021 7:35a ETBenzinga Stock Analysis
      👍️0
      crudeoil24 crudeoil24 4 years ago
      Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The Company's segments include Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment manufactures and sells products used in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Its Biologics Safety Testing segment sells specialized analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. The Company's Protein Detection segment sells labeling and detection reagents for researchers in immunohistochemistry.
      👍️0

      Your Recent History

      NASDAQ
      MRVI
      Maravai LifeSciences
      Delayed Upgrade Clock